Literature DB >> 17566973

Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression.

Mingfu Wu1, Xiangyang Bai, Gang Xu, Juncheng Wei, Tao Zhu, Yongtao Zhang, Qiong Li, Ping Liu, Anping Song, Liangpin Zhao, Chen Gang, Zhiqiang Han, Shixuan Wang, Jianfeng Zhou, Yunpin Lu, Ding Ma.   

Abstract

To better understand the molecular mechanisms of prostate cancer (PCA) dissemination and to develop new anti-metastasis therapies, key regulatory molecules involved in PCA metastasis were identified in two human androgen-independent PCA cell lines, highly metastatic 1E8-H and lowly metastatic 2B4-L cells. Through 2-DE and MS analyses, 12 proteins with different expression levels in the two cell lines were identified. The following proteins were found to be significantly up-regulated in 1E8-H cells compared with 2B4-L cells: gp96 precursor, calreticulin precursor, vimentin (VIM), Hsp90alpha, peroxiredoxin 2, HNRPH1, ezrin, T-complex protein 1, alpha subunit, and hypothetical protein mln2339. In contrast, heart L-lactate dehydrogenase H chain, annexin I, and protein disulfide isomerase were notably down-regulated in 1E8-H cells compared with 2B4-L cells. To our knowledge, this study is the first to demonstrate that up-regulation of VIM expression positively correlates with the invasion and metastasis of androgen-independent PCA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566973     DOI: 10.1002/pmic.200600643

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  26 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

Review 2.  Long Non-coding RNAs and their Role in Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Rüdiger Rüger
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

3.  Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression.

Authors:  Yi-Chien Lu; Chiung-Nien Chen; Bojeng Wang; Wen-Ming Hsu; Szu-Ta Chen; King-Jen Chang; Cheng-Chi Chang; Hsinyu Lee
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

4.  Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.

Authors:  Bilal Bin Hafeez; Joseph W Fischer; Ashok Singh; Weixiong Zhong; Ala Mustafa; Louise Meske; Mohammad Ozair Sheikhani; Ajit Kumar Verma
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-27

5.  Plasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcoma.

Authors:  Yingqi Hua; Xiaofang Jia; Mengxiong Sun; Longpo Zheng; Lin Yin; Lijun Zhang; Zhengdong Cai
Journal:  Tumour Biol       Date:  2011-06-25

6.  Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.

Authors:  Lin Lin; Guangzhi Wang; Jianguang Ming; Xiangqi Meng; Bo Han; Bo Sun; Jinquan Cai; Chuanlu Jiang
Journal:  Tumour Biol       Date:  2016-10-04

7.  Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Authors:  Amjad P Khan; Laila M Poisson; Vadiraja B Bhat; Damian Fermin; Rong Zhao; Shanker Kalyana-Sundaram; George Michailidis; Alexey I Nesvizhskii; Gilbert S Omenn; Arul M Chinnaiyan; Arun Sreekumar
Journal:  Mol Cell Proteomics       Date:  2009-11-09       Impact factor: 5.911

8.  Development and characterization of a novel method for the analysis of gene expression patterns in lymphatic endothelial cells derived from primary breast tissues.

Authors:  Mingfu Wu; Lingfei Han; Yanyan Shi; Gang Xu; Juncheng Wei; Luanyin You; Yin Chen; Tao Zhu; Qiong Li; Shuang Li; Li Meng; Yunpin Lu; Jianfeng Zhou; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-21       Impact factor: 4.553

9.  Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo.

Authors:  Xueping Zhang; Marcia V Fournier; Joy L Ware; Mina J Bissell; Adly Yacoub; Zendra E Zehner
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

10.  α7 helix region of αI domain is crucial for integrin binding to endoplasmic reticulum chaperone gp96: a potential therapeutic target for cancer metastasis.

Authors:  Feng Hong; Bei Liu; Gabriela Chiosis; Daniel T Gewirth; Zihai Li
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.